These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 24493493)

  • 21. 2007 Guideline update for unstable angina/non-ST-segment elevation myocardial infarction: focus on antiplatelet and anticoagulant therapies.
    Coons JC; Battistone S
    Ann Pharmacother; 2008 Jul; 42(7):989-1001. PubMed ID: 18577763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of antiplatelet and antithrombotic therapy in acute coronary syndrome patients with chronic kidney disease.
    Basra SS; Tsai P; Lakkis NM
    J Am Coll Cardiol; 2011 Nov; 58(22):2263-9. PubMed ID: 22093501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New oral anticoagulant agents: the quandary of anticoagulation in the elderly].
    Páramo JA
    Med Clin (Barc); 2013 Oct; 141(8):346-8. PubMed ID: 23831406
    [No Abstract]   [Full Text] [Related]  

  • 24. [New anticoagulants: dabigatran, rivaroxaban and apixaban].
    Vargas Ruiz AG; Ramírez López AN; Medina Viramontes ME
    Gac Med Mex; 2012; 148(3):257-64. PubMed ID: 22820359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Introduction].
    Valle Bernad R
    Rev Clin Esp; 2012 Jan; 212 Suppl 1():1-2. PubMed ID: 23117645
    [No Abstract]   [Full Text] [Related]  

  • 26. New oral anticoagulants for the treatment of venous thromboembolism.
    Agnelli G; Becattini C; Franco L
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):151-61. PubMed ID: 23953903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel oral anticoagulation in management of venous thromboembolism, atrial fibrillation, and acute coronary syndrome.
    Khemasuwan D; Suramaethakul N
    Clin Appl Thromb Hemost; 2012 Sep; 18(5):476-86. PubMed ID: 22387584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
    Cheng JW; Barillari G
    J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New oral anticoagulants vs. warfarin treatment: no need for pharmacogenomics?
    Baker WL; Chamberlin KW
    Clin Pharmacol Ther; 2014 Jul; 96(1):17-9. PubMed ID: 24942397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving adjunctive pharmacotherapy for primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: beyond the HORIZONS-AMI trial.
    Kereiakes DJ
    Rev Cardiovasc Med; 2009; 10(2):72-82. PubMed ID: 19593319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disadvantages of VKA and requirements for novel anticoagulants.
    Shameem R; Ansell J
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):103-14. PubMed ID: 23953899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triple therapy: boon or bane for high-risk CV patients?
    Phillippe HM; Baty SR; Griffith CB
    J Fam Pract; 2011 Apr; 60(4):187-92. PubMed ID: 21472149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel oral anticoagulants for VTE prevention in orthopedic surgery: overview of phase 3 trials.
    Friedman RJ
    Orthopedics; 2011 Oct; 34(10):795-804. PubMed ID: 21956181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
    Mantha S; Ansell J
    Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New directions in anticoagulation.
    Alpert JS
    Am J Med; 2012 Mar; 125(3):217-8. PubMed ID: 22340912
    [No Abstract]   [Full Text] [Related]  

  • 36. Switching between oral anticoagulants.
    Strasser KM; Qasem A; Madhusudhana S
    Hosp Pract (1995); 2014 Aug; 42(3):68-74. PubMed ID: 25255408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New antithrombotics for secondary prevention of acute coronary syndrome.
    Goto S; Tomita A
    Clin Cardiol; 2014 Mar; 37(3):178-87. PubMed ID: 24452610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiplatelet drug use in patients with non-ST-segment elevation acute coronary syndromes.
    Aronow WS
    Postgrad Med; 2013 Jan; 125(1):51-8. PubMed ID: 23391671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New anticoagulants].
    Godier A; Martin AC; Lakhdari M; Samama CM
    Rev Prat; 2011 Nov; 61(9):1239-43. PubMed ID: 22308807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contemporary use of antiplatelet therapies in percutaneous coronary interventions.
    Saw J; Moliterno DJ
    Coron Artery Dis; 2003 Aug; 14(5):373-80. PubMed ID: 12878902
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.